EE284 Cost-Effectiveness of Pembrolizumab in Combination With Chemotherapy As First-Line Treatment of Advanced or Metastatic Esophageal Cancer or HER2-Negative Gastroesophageal Junction Adenocarcinoma in France

T Aparicio, C Mackosso, L Cagnan, L Bensimon, B Tehard, M Boussahoua, S Zhang,T Qu, Y Meng, E François

Value in Health（2022）

引用 0|浏览0

暂无评分

关键词

pembrolizumab,metastatic esophageal cancer,cost-effectiveness cost-effectiveness,chemotherapy,first-line

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要